Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B

Slides:

Advertisements

Similar presentations

Elizabeth A. David, MD, David T

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Joshua E. Rosen, BASc, Hari B

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Ravi Rajaram, MD, MSc, Jennifer L

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Castigliano M. Bhamidipati, DO, MS, George J

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure Jessamy A. Boyd, MD, Jessica L. Hubbs,

Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum Kenneth A. Kesler, MD, Laura E. Kruter,

A Comparison of Length of Stay, Readmission Rate, and Facility Reimbursement After Lobectomy of the Lung Richard K. Freeman, MD, MBA, J. Russell Dilts,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgical Treatment of Metachronous Second Primary Lung Cancer

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Pulmonary Resection for Lung Cancer in Octogenarians

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Leora J. Tesche, MD, Richard H. Feins, MD, Matthew M

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Subcategorization of Resectable Non-Small Cell Lung Cancer Involving Neighboring Structures Noriaki Sakakura, MD, Shoichi Mori, MD, Futoshi Ishiguro,

Distribution and Likelihood of Lymph Node Metastasis Based on the Lobar Location of Nonsmall-Cell Lung Cancer Robert J. Cerfolio, MD, Ayesha S. Bryant,

Specialty Training and Mortality After Esophageal Cancer Resection

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Presentation transcript:

Variability in Defining T1N0 Non-Small Cell Lung Cancer Impacts Locoregional Failure and Survival Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B. Marks, MD, Richard H. Feins, MD, Benjamin E. Haithcock, MD, Nirmal K. Veeramachaneni, MD The Annals of Thoracic Surgery Volume 90, Issue 5, Pages 1645-1650 (November 2010) DOI: 10.1016/j.athoracsur.2010.06.033 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Distribution of the number of N2 stations analyzed. The Annals of Thoracic Surgery 2010 90, 1645-1650DOI: (10.1016/j.athoracsur.2010.06.033) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Freedom from locoregional failure in patients with defined N1 nodal stations (green line) analyzed versus unspecified nodal stations, namely, “peribronchial lymph nodes” (blue line). All patients had pathologic stage Ia lung cancer. Data from patients with pathologic T1N1 disease (orange line) are presented for comparison. The data for pT1 N1 patients were obtained through a similar review of the UNC surgical patients contemporaneous with the 119 patients who are the focus of this report. The Annals of Thoracic Surgery 2010 90, 1645-1650DOI: (10.1016/j.athoracsur.2010.06.033) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Freedom from local failure for patients with completely resected stage Ia lung cancer. The Annals of Thoracic Surgery 2010 90, 1645-1650DOI: (10.1016/j.athoracsur.2010.06.033) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Disease-free survival of patients with defined N1 nodal stations (green line) analyzed versus unspecified nodal stations, namely, “peribronchial lymph nodes” (blue line). All patients had pathologic stage Ia lung cancer. The Annals of Thoracic Surgery 2010 90, 1645-1650DOI: (10.1016/j.athoracsur.2010.06.033) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions